Company Asterias Biotherapeutics Inc OTC Bulletin Board
Equities
US04624N1072
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 53 | 07/03/19 |
Munish Mehra
PRN | Corporate Officer/Principal | - | - |
George Samuel
SEC | Corporate Secretary | 43 | - |
Frank Lanza
AUD | Comptroller/Controller/Auditor | 62 | 31/12/15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 55,658,684 | 54,849,986 ( 98.55 %) | 0 | 98.55 % |
Company contact information
Asterias Biotherapeutics, Inc.
2173 Salk Avenue Suite 200
92008, Carlsbad
+510 456 3800
http://asteriasbiotherapeutics.com/Sector
1st Jan change | Capi. | |
---|---|---|
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- AST Stock
- Stock
- Company Asterias Biotherapeutics Inc